For the first time in Malaysia, patients living with early Alzheimer’s disease have access to a treatment that goes beyond managing symptoms. Eisai Malaysia has officially introduced LEQEMBI (lecanemab), the country’s first disease-modifying therapy (DMT) for Alzheimer’s disease, offering new hope by targeting the underlying cause of the condition rather than simply easing its symptoms. This significant milestone…